EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes

Nerea Albaladejo-Carrasco iD, Clara Furió-Novejarque iD, Lía Nattero-Chávez iD, Jorge Bondia iD, José-Luis Díez iD

Bioengineering & Translational Medicine · 2026-11 · 11 (6)

DOI: 10.1002/btm2.70168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 15.09.2026. Verfasst von Nerea Albaladejo-Carrasco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Automática e Informática Industrial Universitat Politècnica de València Valencia Spain. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women with type 1 diabetes mellitus (T1DM) may experience challenges in glycemic control driven by biological sex–specific hormonal fluctuations. Across the menstrual cycle, clinical studies have reported phase‐dependent variations in time in range (TIR), with periods of increased hyperglycemia associated with changes in insulin sensitivity (IS). However, IS is not the sole metabolic process influenced by ovarian hormones; multiple regulatory mechanisms involved in glucose homeostasis appear to be modulated, adding complexity to insulin therapy management in women with T1DM using current automated insulin delivery (AID) systems. In this context, the present work conducts a narrative review of physiologically based mathematical models that seek to couple ovarian hormonal dynamics with glucose–insulin regulation. The analysis reveals a limited number of models that explicitly integrate these interacting systems, highlighting important gaps in the current modeling landscape. These findings underscore the need for physiologically informed models that more accurately represent hormonal–metabolic interactions in women with T1DM, with potential implications for the future development of sex‐specific simulation tools and adaptive closed‐loop insulin delivery strategies.

Schlagwörter

Stichwörter der Autor:innen

automated insulin delivery systemsmenstrual cycleovarian hormonesphysiological controlsex‐specific differencestype 1 diabetes

Autor:innen und Institutionen

  • Instituto Universitario de Automática e Informática Industrial Universitat Politècnica de València Valencia Spain.
  • Hospital Universitario Ramón y Cajal Madrid Spain.
  • CIBERDEM, ISCIII Madrid Spain.

ORCID-Profile: Nerea Albaladejo-Carrasco, Clara Furió-Novejarque, Lía Nattero-Chávez, Jorge Bondia, José-Luis Díez

Zitieren

APA

Albaladejo-Carrasco, N., Furió-Novejarque, C., Nattero-Chávez, L., Bondia, J., & Díez, J. L. (2026). Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes. Bioengineering & Translational Medicine, 11(6). https://doi.org/10.1002/btm2.70168

Vancouver

Albaladejo-Carrasco N, Furió-Novejarque C, Nattero-Chávez L, Bondia J, Díez JL. Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes. Bioengineering & Translational Medicine. 2026;11(6). doi:10.1002/btm2.70168

BibTeX
@article{AlbaladejoCarrasco2026,
  author = {Albaladejo-Carrasco, Nerea and Furió-Novejarque, Clara and Nattero-Chávez, Lía and Bondia, Jorge and Díez, José-Luis},
  title = {Modeling ovarian hormone effects on glucose–insulin control in type 1 diabetes},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  volume = {11},
  number = {6},
  doi = {10.1002/btm2.70168}
}
Kostenlos starten →